Cinna 25 mg

Indication

Symptomatic treatment of nausea and vertigo due to Ménière's disease and other labyrinthine disturbances; prevention of motion sickness; and management of peripheral arterial disease.

Ingredients

• Cinnarizine 25 mg

Direction

Adults: 15–30 mg three times daily. For motion sickness, 30 mg 2 hours before travel and 15 mg every 8 hours during travel. Follow the package leaflet or a clinician's advice.

Side effects

• Consult a doctor or pharmacist before use and stop if irritation or allergy occurs.

Precautions

• Keep out of reach of children. Use as directed by a doctor or pharmacist.